Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXA2R | P21731 | 14/20 | 0.57 |
| ▸ | MGLL | Q99685 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4785116 | 0.92 | TBXA2R (0.58) | TBXA2RMGLLEPHX2 | |
| SCHEMBL4813956 | 0.86 | MGLL (0.55) | TBXA2RMGLLMEN1MAPTKMT2A | |
| SCHEMBL4784488 | 0.86 | EPHX2 (0.48) | TBXA2RMEN1KMT2AEPHX2 | |
| SCHEMBL4683382 | 0.84 | KDR (0.51) | MEN1KMT2ASMN1; SMN2EPHX2 | |
| SCHEMBL4687617 | 0.84 | EPHX2 (0.47) | TBXA2RMGLLMEN1MAPTKMT2A | |
| SCHEMBL4787995 | 0.84 | TBXA2R (0.61) | TBXA2RMGLLMEN1MAPTKMT2A | |
| SCHEMBL4787488 | 0.84 | TBXA2R (0.61) | TBXA2RMGLLMEN1MAPTKMT2A | |
| SCHEMBL4785258 | 0.84 | KDR (0.48) | TBXA2RMEN1MAPTKMT2AEPHX2 | |
| SCHEMBL4232323 | 0.83 | TAS1R3 (0.53) | MEN1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL4786978 | 0.82 | TBXA2R (0.56) | TBXA2RMGLLMEN1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1879887-A2 | NPY ANTAGONISTS, PREPARATION AND USE | Cerep (FR) | 2008-01-23 | — | — | EP | disclosed |
| WO-2006108965-A2 | NPY ANTAGONISTS, PREPARATION AND USE | CEREP (FR) | 2006-10-19 | — | — | WO | disclosed |